Biolegend, 135505, PE anti-mouse CD115 (CSF-1R) Antibody, 50μg

CSF-1R, also known as CD115 and M-CSFR, is a single-pass type I membrane protein and member of the platelet-derived growth factor receptor family. This c-fms (Fms proto-oncogene) gene product's natural ligands include M-CSF and IL-34. Structural studies of CD115 have described an Ig-like extracellular domain, a transmembrane domain, an intracellular juxtamembrane domain, a split tyrosine kinase domain, and a C-terminal tail receptor. Receptor activation induces homodimerization in addition to phosphorylation and ubiquitination of intracellular residues. CD115 directly influences tissue macrophage and osteoclast differentiation and proliferation. It is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid and conventional dendritic cells, and osteoclasts.
50μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Additional reported applications (for the relevant formats) include: blocking of ligand binding1. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays.It has been reported that CD115 can be rapidly internalized, especially when samples are exposed to room temperature. Approximate 33% decrease in CD115 expression has been observed between 0 and 4 hours after sample collection, while overnight incubation of the cells results in complete CD115 downregulation. Pre-treatment with EDTA and low temperatures (2 to 8°C) helps in maintaining surface expression of CD1154.
Application References(PubMed link indicates BioLegend citation): Sudo T, et al. 1995. Oncogene 11:2469. Murayama T, et al. 1999. Circulation 99:1740. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. PubMed Breslin WL, et al. 2013. J Immunol Methods. 390(1-2):1 PubMed Dong L, et al. 2016. Nature. 539:304–308. PubMed
Product Citations: Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed Combes F, et al. 2018. Neoplasia. 20:848. PubMed Sierro F, et al. 2017. Immunity. 47:374. PubMed Abdel-Haq R, et al. 2022. Elife. 11:. PubMed Rosina M, et al. 2022. Cell Metab. 34:533. PubMed Liang Y, et al. 2021. Cell Death Differ. 28:2728. PubMed Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed Li T, et al. 2022. J Exp Med. 219: . PubMed Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed Roberts JL, et al. 2022. Bone. 157:116310. PubMed Fernández-García V, et al. 2022. Biomed Pharmacother. 148:112769. PubMed Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed Takacs E, et al. 2017. J Immunol. 198:239. PubMed Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed Lee MH, et al. 2018. J Immunol Res. 2018:1601079. PubMed Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed Hreha TN, et al. 2020. Front Immunol. 1.597916667. PubMed Sakai M, et al. 2020. Immunity. 51(4):655-670. PubMed Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed Bowers E, et al. 2018. Nat Med. 24:95. PubMed Bratti M, et al. 2022. Front Immunol. 13:1029759. PubMed Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed Yang F, et al. 2020. Cancer Res. 80:3677. PubMed Smith C, et al. 2012. Cancer Discovery. 2:722. PubMed Distel E, et al. 2014. Circ Res . 115:759. PubMed He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed Voisin M, et al. 2021. Commun Biol. 4:420. PubMed Eisele AS, et al. 2022. Elife. 11:. PubMed Barman PK, et al. 2019. J Immunol. 202:2720. PubMed Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed Anderson SR, et al. 2019. Cell Rep. 27:2002. PubMed La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed Kuhn JA, et al. 2021. Elife. 10:. PubMed Aktories P, et al. 2022. Cell Rep Methods. 2:100260. PubMed Ding P, et al. 2022. Bone Res. 10:42. PubMed Gadd V, et al. 2016. PLoS One. 11: 0157771. PubMed Bouchareychas L, et al. 2020. Cell Reports. 32(2):107881. PubMed Li W, et al. 2021. PLoS Pathog. 17:e1009462. PubMed Johansson J, et al. 2013. J Neurosci. 33:16016. PubMed Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed Clemente C, et al. 2018. Nat Commun. 9:910. PubMed Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed Chen S, et al. 2014. Biochem Biophys Res Commun. 446:1002. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Foster G, et al. 2015. J Immunol. 195: 5380 - 5392. PubMed Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed Ryu J, et al. 2013. Circulation. 127:710. PubMed Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
RRID: AB_1937254 (BioLegend Cat. No. 135505) AB_1937253 (BioLegend Cat. No. 135506)
Structure: Ig superfamily, 145 kD
Distribution: Monocytes/macrophages, peritoneal exudate cells, plasmacytoid and conventional dendritic cells, osteoclasts
Function: Growth factor receptor, tyrosine kinase
Ligand/Receptor: Macrophage colony stimulating factor (M-CSF), IL-34
Cell Type: Dendritic cells, Macrophages, Monocytes, Osteoclasts
Biology Area: Immunology
Molecular Family: CD Molecules, Cytokine/Chemokine Receptors
Antigen References: Sudo T, et al. 1995 Oncogene 11:2469. Murayama T, et al. 1999 Circulation 99:1740. Goswami S, et al. 2005 Cancer Res. 65:5278. Yu W, et al. 2008 J. Leuko. Biol. 84:852.
Gene ID: 12978
UniProt: View information about CD115 on UniProt.org
Clone: AFS98
Regulatory Status: RUO
Other Names: CSF-1R, M-CSFR, c-fms
Isotype: Rat IgG2a, κ
Q: What type of PE do you use in your conjugates?
A: We use R-PE in our conjugates.
Q: Why do I have a weak CD115 staining?
A: It has been reported that CD115 can be rapidly internalized, especially when samples are exposed to room temperature. Approximate 33% decrease in CD115 expression has been observed between 0 and 4 hours after sample collection, while overnight incubation of the cells results in complete CD115 downregulation.  Pre-treatment with EDTA and low temperatures (2 - 8°C) helps in maintaining surface expression of CD115. In addition, brief fixation of the cells with Fixation Buffer (Cat. No. 420801) for 10 minutes will block CD115 internalization.